iShares Biotechnology ETF IBB

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IBB

Will IBB outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Biotechnology ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBB

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings51.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

8.791B
Healthcare

Amgen Inc

8.22943M
Healthcare

Vertex Pharmaceuticals Inc

7.69881M
Healthcare

Moderna Inc

6.61758M
Healthcare

Regeneron Pharmaceuticals Inc

6.13703M
Healthcare

argenx SE ADR

3.59412M
Healthcare

Natera Inc

2.90333M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.59297M
Healthcare

Biogen Inc

2.51288M
Healthcare

BeOne Medicines Ltd ADR

2.36271M
Healthcare

Sponsor Center